An in vitro microfluidic model of platelet aggregation

Cardiovascular disease is the leading cause of death in both the U.S. and Europe^1,2; however, no regulatory assays are currently available to predict drug/chemical-linked effects on atherosclerosis (gradual narrowing of the arteries).